e-ISSN: Pending
Negative / Null Result ReportOpen accessDiseases of the blood and blood-forming organs

Outcomes of autologous transplantation for multiple myeloma according to different induction regimens

Edvan de Queiroz Crusoe; Fabiana Higashi; Maria Paula Nalesso Camargo Padilha; Eliana Cristina Martins Miranda; Adriana Alvares Quero; Manuella de Souza Sampaio Almeida; Ana Lucia M. Peres; Priscilla Cury · 2014 · Revista Brasileira de Hematologia e Hemoterapia

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Background: Induction therapy followed by high-dose chemotherapy and autologous transplantation is the standard treatment for suitable patients with multiple myeloma. Objective: The aim of this study was to assess whether induction therapy with thalidomidecontaining regimens was associated with improved results compared to vincristine, doxorubicin, and dexamethasone, and whether cyclophosphamide, thalidomide, and dexamethasone were associated with better results than thalidomide and dexamethasone. Methods: The records of 152 patients who underwent autologous transplantation at this institution

Abstract by Edvan de Queiroz Crusoe; Fabiana Higashi; Maria Paula Nalesso Camargo Padilha; Eliana Cristina Martins Miranda; Adriana Alvares Quero; Manuella de Souza Sampaio Almeida; Ana Lucia M. Peres; Priscilla Cury, Revista Brasileira de Hematologia e Hemoterapia (2014) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.5581/1516-8484.20140008